Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer|June 4, 2008
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trialDeborah T Blumenthal, Cathryn Rankin, Harmon J Eyre, et al.
Cancer|October 15, 2013
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trialCharles S Fuchs, Marwan Fakih, Lee Schwartzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidinesHeinz-Josef Lenz, Eric Van Cutsem, Shirin Khambata-Ford, et al.
The Oncologist|February 18, 2017
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal CancerJohanna C Bendell, Howard Hochster, Lowell L Hart, et al.
Cancer|April 23, 2013
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 studyJeffrey R Infante, Tony R Reid, Allen L Cohn, et al.
The Lancet. Oncology|March 30, 2019
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trialVicky Makker, Drew Rasco, Nicholas J Vogelzang, et al.
Journal for Immunotherapy of Cancer|January 19, 2024
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146Vicky Makker, Matthew H Taylor, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2020
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial CancerVicky Makker, Matthew H Taylor, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic CancerMitesh J Borad, Shantan G Reddy, Nathan Bahary, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trialHeinz-Josef Lenz, Aparna Parikh, David R Spigel, et al.
Pageof 3